On July 27, 2022, AmeriHealth HMO, Inc. and AmeriHealth Insurance Company of New Jersey (collectively, AmeriHealth New Jersey) announced a new agreement with Thyme Care, an oncology care management company providing high-touch, technology-enabled cancer navigation. Beginning January 1, 2023, Thyme Care will provide AmeriHealth New Jersey commercial members who have a cancer diagnosis with additional support that is focused on improving outcomes and overcoming health disparities.

Using its analytics platform, Thyme Care will help AmeriHealth New Jersey more quickly identify members who need help navigating their cancer journey. Once a member is identified, Thyme Care's team of oncology nurses and resource specialists will contact them to offer education and guidance, as well as advocate for patients and support their existing treatment plans. They will also coordinate with providers and AmeriHealth New Jersey member-facing teams to ensure their care is aligned and meets the patients' unique needs.

Thyme Care can extend the efforts of providers and their practices by providing members with disease and treatment education, appointment coordination, financial assistance applications, and other critical services to address barriers to care and reduce the risk of unnecessary acute care utilization.

Thyme Care will be available to AmeriHealth New Jersey commercial members at no additional cost. Services like prescriptions or lab work will continue to go through a member's health plan and members will be responsible for any associated costs.